# Filing Detail

Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-21-018886
Filing Date
2021-08-06
Accepted
2021-08-06 16:31:13
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form424b3.htm | 424B3 | 6535477
2 |  | s4_001.jpg | GRAPHIC | 3436
3 |  | annex-d_001.jpg | GRAPHIC | 243976
4 |  | annex-d_002.jpg | GRAPHIC | 195877
| Complete submission text file | 0001493152-21-018886.txt |  | 7147483

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-257272 | Film No.: 211153358
SIC: 2834 Pharmaceutical Preparations